BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 15125929)

  • 1. Synthesis and structure-activity relationship of 2-(aminoalkyl)-3,3a,8,12b-tetrahydro-2H-dibenzocyclohepta[1,2-b]furan derivatives: a novel series of 5-HT(2A/2C) receptor antagonists.
    Cid J; Alonso JM; Andrés JI; Fernández J; Gil P; Iturrino L; Matesanz E; Meert TF; Megens A; Sipido VK; Trabanco AA
    Bioorg Med Chem Lett; 2004 Jun; 14(11):2765-71. PubMed ID: 15125929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and structure-activity relationship of 2-(aminoalkyl)-2,3,3a,8-tetrahydrodibenzo[c,f]isoxazolo[2,3-a]azepine derivatives: a novel series of 5-HT(2A/2C) receptor antagonists. Part 2.
    Andrés JI; Alcázar J; Alonso JM; Díaz A; Fernández J; Gil P; Iturrino L; Matesanz E; Meert TF; Megens A; Sipido VK
    Bioorg Med Chem Lett; 2002 Jan; 12(2):249-53. PubMed ID: 11755365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2-Alkyl-4-aryl-pyrimidine fused heterocycles as selective 5-HT2A antagonists.
    Shireman BT; Dvorak CA; Rudolph DA; Bonaventure P; Nepomuceno D; Dvorak L; Miller KL; Lovenberg TW; Carruthers NI
    Bioorg Med Chem Lett; 2008 Mar; 18(6):2103-8. PubMed ID: 18282705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel 2-N,N-dimethylaminomethyl-2,3,3a,12b-tetrahydrodibenzo[b,f]furo[2,3-d]oxepin derivatives displaying combined norepinephrine reuptake inhibition and 5-HT2A/2C receptor antagonism.
    Bartolomé JM; Alcudia A; Andrés JI; Cid JM; García M; Megens A; Toledo MA; Trabanco AA
    Bioorg Med Chem Lett; 2005 Jun; 15(11):2898-901. PubMed ID: 15911276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and pharmacological characterization of a series of geometrically constrained 5-HT(2A/2C) receptor ligands.
    Chambers JJ; Parrish JC; Jensen NH; Kurrasch-Orbaugh DM; Marona-Lewicka D; Nichols DE
    J Med Chem; 2003 Jul; 46(16):3526-35. PubMed ID: 12877591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and structure-activity relationships of a series of benzazepine derivatives as 5-HT2C receptor agonists.
    Shimada I; Maeno K; Kondoh Y; Kaku H; Sugasawa K; Kimura Y; Hatanaka K; Naitou Y; Wanibuchi F; Sakamoto S; Tsukamoto S
    Bioorg Med Chem; 2008 Mar; 16(6):3309-20. PubMed ID: 18083579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2-(Dimethylaminomethyl)-tetrahydroisoxazolopyridobenzazepine derivatives. Synthesis of a new 5-HT(2C) antagonist with potential anxiolytic properties.
    Andrés JI; Alonso JM; Fernández J; Iturrino L; Martínez P; Meert TF; Sipido VK
    Bioorg Med Chem Lett; 2002 Dec; 12(24):3573-7. PubMed ID: 12443779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and biological evaluation of (phenylpiperazinyl-propyl)arylsulfonamides as selective 5-HT(2A) receptor antagonists.
    Yoo E; Yoon J; Pae AN; Rhim H; Park WK; Kong JY; Park Choo HY
    Bioorg Med Chem; 2010 Feb; 18(4):1665-75. PubMed ID: 20096593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Position 5.46 of the serotonin 5-HT2A receptor contributes to a species-dependent variation for the 5-HT2C agonist (R)-9-ethyl-1,3,4,10b-tetrahydro-7-trifluoromethylpyrazino[2,1-a]isoindol-6(2H)-one: impact on selectivity and toxicological evaluation.
    Miller KJ; Wu GY; Varnes JG; Levesque P; Li J; Li D; Robl JA; Rossi KA; Wacker DA
    Mol Pharmacol; 2009 Dec; 76(6):1211-9. PubMed ID: 19767451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Substituted naphthofurans as hallucinogenic phenethylamine-ergoline hybrid molecules with unexpected muscarinic antagonist activity.
    Monte AP; Marona-Lewicka D; Lewis MM; Mailman RB; Wainscott DB; Nelson DL; Nichols DE
    J Med Chem; 1998 Jun; 41(12):2134-45. PubMed ID: 9622555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New serotonin 5-HT(2A), 5-HT(2B), and 5-HT(2C) receptor antagonists: synthesis, pharmacology, 3D-QSAR, and molecular modeling of (aminoalkyl)benzo and heterocycloalkanones.
    Brea J; Rodrigo J; Carrieri A; Sanz F; Cadavid MI; Enguix MJ; Villazón M; Mengod G; Caro Y; Masaguer CF; Raviña E; Centeno NB; Carotti A; Loza MI
    J Med Chem; 2002 Jan; 45(1):54-71. PubMed ID: 11754579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual acting norepinephrine reuptake inhibitors and 5-HT(2A) receptor antagonists: Identification, synthesis and activity of novel 4-aminoethyl-3-(phenylsulfonyl)-1H-indoles.
    Heffernan GD; Coghlan RD; Manas ES; McDevitt RE; Li Y; Mahaney PE; Robichaud AJ; Huselton C; Alfinito P; Bray JA; Cosmi SA; Johnston GH; Kenney T; Koury E; Winneker RC; Deecher DC; Trybulski EJ
    Bioorg Med Chem; 2009 Nov; 17(22):7802-15. PubMed ID: 19836247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis by microwave irradiation and binding properties of novel 5-HT(1A) receptor ligands.
    Caliendo G; Fiorino F; Perissutti E; Severino B; Gessi S; Cattabriga E; Borea PA; Santagada V
    Eur J Med Chem; 2001; 36(11-12):873-86. PubMed ID: 11755230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and evaluation of 5-HT(2A) and 5-HT(2C) receptor binding affinities of novel pyrimidine derivatives.
    Bózsing D; Simonek I; Simig G; Jakóczi I; Gacsályi I; Lévay G; Tihanyi K; Schmidt E
    Bioorg Med Chem Lett; 2002 Nov; 12(21):3097-9. PubMed ID: 12372510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and structure-activity relationship of 2-(aminoalkyl)-2,3,3a,8-tetrahydrodibenzo[c,f]isoxazolo[2,3-a]azepine derivatives: a novel series of 5-HT(2A/2C) receptor antagonists. Part 1.
    Andrés JI; Alcázar J; Alonso JM; Díaz A; Fernández J; Gil P; Iturrino L; Matesanz E; Meert TF; Megens A; Sipido VK
    Bioorg Med Chem Lett; 2002 Jan; 12(2):243-8. PubMed ID: 11755364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current status of inverse agonism at serotonin2A (5-HT2A) and 5-HT2C receptors.
    Aloyo VJ; Berg KA; Spampinato U; Clarke WP; Harvey JA
    Pharmacol Ther; 2009 Feb; 121(2):160-73. PubMed ID: 19109993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modification of the structure of 4, 6-disubstituted 2-(4-alkyl-1-piperazinyl)pyridines: synthesis and their 5-HT2A receptor activity.
    Paluchowska MH; Bojarski AJ; Bugno R; Charakchieva-Minol S; Wesołowska A
    Arch Pharm (Weinheim); 2003 Apr; 336(2):104-10. PubMed ID: 12761763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2,5-Disubstituted pyridines: the discovery of a novel series of 5-HT2A ligands.
    Wilson KJ; van Niel MB; Cooper L; Bloomfield D; O'Connor D; Fish LR; MacLeod AM
    Bioorg Med Chem Lett; 2007 May; 17(9):2643-8. PubMed ID: 17314044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, biological activity, and molecular modeling of selective 5-HT(2C/2B) receptor antagonists.
    Forbes IT; Dabbs S; Duckworth DM; Ham P; Jones GE; King FD; Saunders DV; Blaney FE; Naylor CB; Baxter GS; Blackburn TP; Kennett GA; Wood MD
    J Med Chem; 1996 Dec; 39(25):4966-77. PubMed ID: 8960557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and biological activity of 5-styryl and 5-phenethyl-substituted 2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indoles.
    Ivachtchenko AV; Frolov EB; Mitkin OD; Tkachenko SE; Okun IM; Khvat AV
    Bioorg Med Chem Lett; 2010 Jan; 20(1):78-82. PubMed ID: 19945877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.